Latest news
Vistagen’s repeat-dose anxiety nasal spray can’t beat placebo in mid-stage study - PharmaLivePharmaLive · Fri, 07 Aug 2026 13:10:50 GMTFDA approves Replimmune’s immunotherapy for advanced melanoma - PharmaLivePharmaLive · Fri, 07 Aug 2026 13:02:22 GMTSanofi pauses mid-stage lung study amid new CEO’s ‘rigorous portfolio prioritization’ - PharmaLivePharmaLive · Thu, 06 Aug 2026 12:30:21 GMTTakeda wins FDA approval for first drug to treat full range of narcolepsy type 1 symptoms - PharmaLivePharmaLive · Wed, 05 Aug 2026 20:17:20 GMTInnovation times three - PharmaLivePharmaLive · Wed, 05 Aug 2026 10:00:30 GMTPurpose-building an AI offering for drug development - PharmaLivePharmaLive · Wed, 05 Aug 2026 09:46:56 GMTBuilding the trust ecosystem in healthcare influencer marketing - PharmaLivePharmaLive · Wed, 05 Aug 2026 09:00:19 GMTCatching up with Liz Apelles - PharmaLivePharmaLive · Wed, 05 Aug 2026 08:15:42 GMT